Brokerages expect that Addus HomeCare Co. (NASDAQ:ADUS – Get Rating) will post sales of $227.54 million for the current quarter, Zacks reports. Four analysts have made estimates for Addus HomeCare’s earnings, with estimates ranging from $226.10 million to $229.12 million. Addus HomeCare reported sales of $205.30 million in the same quarter last year, which would suggest a positive year over year growth rate of 10.8%. The business is expected to report its next quarterly earnings results after the market closes on Monday, January 1st.
On average, analysts expect that Addus HomeCare will report full-year sales of $960.76 million for the current year, with estimates ranging from $950.58 million to $966.14 million. For the next fiscal year, analysts expect that the firm will post sales of $1.02 billion, with estimates ranging from $1.01 billion to $1.03 billion. Zacks Investment Research’s sales averages are an average based on a survey of analysts that that provide coverage for Addus HomeCare.
Addus HomeCare (NASDAQ:ADUS – Get Rating) last posted its quarterly earnings results on Thursday, February 24th. The company reported $0.86 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.87 by ($0.01). The company had revenue of $224.64 million during the quarter, compared to analysts’ expectations of $226.22 million. Addus HomeCare had a return on equity of 8.97% and a net margin of 5.22%. Addus HomeCare’s revenue for the quarter was up 14.6% compared to the same quarter last year. During the same period last year, the company earned $0.72 earnings per share.
NASDAQ ADUS opened at $84.28 on Monday. The stock has a 50 day moving average of $83.91. The company has a quick ratio of 2.76, a current ratio of 2.76 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $1.34 billion, a price-to-earnings ratio of 30.10, a price-to-earnings-growth ratio of 2.23 and a beta of 0.84. Addus HomeCare has a 52-week low of $68.57 and a 52-week high of $110.32.
In other Addus HomeCare news, CEO R Dirk Allison sold 1,911 shares of the stock in a transaction that occurred on Friday, February 25th. The stock was sold at an average price of $70.57, for a total transaction of $134,859.27. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Brian Poff sold 448 shares of the stock in a transaction that occurred on Wednesday, March 2nd. The shares were sold at an average price of $84.22, for a total value of $37,730.56. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,196 shares of company stock worth $398,605. Insiders own 4.00% of the company’s stock.
Institutional investors have recently made changes to their positions in the company. Okabena Investment Services Inc. acquired a new stake in shares of Addus HomeCare in the fourth quarter worth $31,000. Public Employees Retirement System of Ohio grew its stake in shares of Addus HomeCare by 41.8% in the fourth quarter. Public Employees Retirement System of Ohio now owns 448 shares of the company’s stock worth $42,000 after acquiring an additional 132 shares during the last quarter. Marshall Wace North America L.P. acquired a new stake in shares of Addus HomeCare in the first quarter worth $34,000. Financial Management Professionals Inc. acquired a new stake in shares of Addus HomeCare in the first quarter worth $72,000. Finally, US Bancorp DE grew its stake in shares of Addus HomeCare by 28.1% in the third quarter. US Bancorp DE now owns 871 shares of the company’s stock worth $69,000 after acquiring an additional 191 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.
About Addus HomeCare (Get Rating)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.
- Get a free copy of the StockNews.com research report on Addus HomeCare (ADUS)
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- Iridium Communications Stock is Ready to Return to Orbit
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.